Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EAN 2024 Guideline on the Diagnostic Approach to Oligo/Asymptomatic HyperCKemia.

European journal of neurology·2026
Same author

Management of presymptomatic juvenile patients with late-onset Pompe disease (LOPD).

Neuromuscular disorders : NMD·2025
Same author

1st FSHD European Trial Network workshop:Working towards trial readiness across Europe.

Neuromuscular disorders : NMD·2021
Same author

Dyslexia and cognitive impairment in adult patients with myotonic dystrophy type 1: a clinical prospective analysis.

Journal of neurology·2020
Same author

An integrative correlation of myopathology, phenotype and genotype in late onset Pompe disease.

Neuropathology and applied neurobiology·2019
Same author

Self-diagnosis of a triple trouble.

Neuromuscular disorders : NMD·2018
Same journal

[Prevention strategies in rheumatoid arthritis : From primary prevention to targeted drug interception].

Zeitschrift fur Rheumatologie·2026
Same journal

Methodological concerns and data discrepancies in the indirect treatment comparison of belimumab and anifrolumab.

Zeitschrift fur Rheumatologie·2026
Same journal

Evaluating the comparative efficacy of belimumab vs. anifrolumab in systemic lupus erythematosus: a response.

Zeitschrift fur Rheumatologie·2026
Same journal

[Update: DMARDs for MGUS].

Zeitschrift fur Rheumatologie·2026
Same journal

[A potpourri of diagnoses-Unusual manifestations of a chronic inflammatory bowel disease : Case report].

Zeitschrift fur Rheumatologie·2026
Same journal

[Not measurable but immeasurably important : Fever-The leading symptom of ancient medical theory].

Zeitschrift fur Rheumatologie·2026
See all related articles

Related Experiment Video

Updated: Jun 20, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

[Inflammatory myopathies].

B Schoser1

  • 1Friedrich-Baur-Institut, Neurologische Klinik, Ludwig-Maximilians-Universität München, München. bschoser@med.uni-muenchen.de

Zeitschrift Fur Rheumatologie
|September 17, 2009
PubMed
Summary
This summary is machine-generated.

This review covers immunogenic myopathies, highlighting diagnostic challenges and reclassifications of polymyositis and inclusion body myositis (IBM). New diagnostic criteria impact treatment strategies and the need for muscle biopsies.

Related Experiment Videos

Last Updated: Jun 20, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Area of Science:

  • Neurology
  • Rheumatology
  • Pathology

Context:

  • Inflammatory myopathies encompass infectious, focal, and immunogenic types.
  • Dermatomyositis is the most prevalent immunogenic myopathy, often associated with other autoimmune disorders.
  • The diagnostic landscape of polymyositis and inclusion body myositis (IBM) is evolving, with reclassifications impacting patient categorization.

Purpose:

  • To review the clinical features, diagnostic techniques, pathogenesis, and therapy of immunogenic myopathies.
  • To discuss the diagnostic re-evaluation of polymyositis and sporadic inclusion body myositis (IBM).
  • To highlight the implications of these reclassifications on therapeutic decisions and the role of muscle biopsy.

Summary:

  • Immunogenic myopathies, including dermatomyositis, polymyositis, and inclusion body myositis (IBM), present complex diagnostic challenges.
  • Recent reclassifications suggest some polymyositis cases are hereditary muscular dystrophies or IBM, while sporadic IBM may be hereditary or part of protein aggregate/myofibrillar myopathies.
  • These diagnostic shifts create therapeutic dilemmas and necessitate a re-evaluation of muscle biopsy indications.

Impact:

  • The evolving classification of inflammatory myopathies necessitates a critical review of diagnostic criteria.
  • Reclassification impacts treatment strategies, particularly for polymyositis and inclusion body myositis (IBM).
  • The findings underscore the need for careful consideration of muscle biopsy in diagnosing and managing these complex neuromuscular conditions.